Enhanced biosynthesis of poly(3‐hydroxybutyrate) in engineered strains of Pseudomonas putida via increased malonyl‐ CoA availability
Microbial Biotechnology · 2024-11 · 17 (11)
DOI: 10.1111/1751-7915.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, 2024-11. Verfasst von Giusi Favoino und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark. Hauptthemen laut MEDLINE: Pseudomonas putida, Malonyl Coenzyme A, Metabolic Engineering, Polyesters. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Malonyl‐coenzyme A (CoA) is a key precursor for the biosynthesis of multiple value‐added compounds by microbial cell factories, including polyketides, carboxylic acids, biofuels, and polyhydroxyalkanoates. Owing to its role as a metabolic hub, malonyl‐CoA availability is limited by competition in several essential metabolic pathways. To address this limitation, we modified a genome‐reduced Pseudomonas putida strain to increase acetyl‐CoA carboxylation while limiting malonyl‐CoA utilization. Genes involved in sugar catabolism and its regulation, the tricarboxylic acid (TCA) cycle, and fatty acid biosynthesis were knocked‐out in specific combinations towards increasing the malonyl‐CoA pool. An enzyme‐coupled biosensor, based on the rppA gene, was employed to monitor malonyl‐CoA levels in vivo. RppA is a type III polyketide synthase that converts malonyl‐CoA into flaviolin, a red‐colored polyketide. We isolated strains displaying enhanced malonyl‐CoA availability via a colorimetric screening method based on the RppA‐dependent red pigmentation; direct flaviolin quantification identified four engineered strains had a significant increase in malonyl‐CoA levels. We further modified these strains by adding a non‐canonical pathway that uses malonyl‐CoA as precursor for poly(3‐hydroxybutyrate) biosynthesis. These manipulations led to increased polymer accumulation in the fully engineered strains, validating our general strategy to boost the output of malonyl‐CoA–dependent pathways in P . putida .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
- Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.
ORCID-Profile: Giusi Favoino, Nicolas Krink, Tobias Schwanemann, Nick Wierckx, Pablo I Nikel
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Favoino, G., Krink, N., Schwanemann, T., Wierckx, N., & Nikel, P. I. (2024). Enhanced biosynthesis of poly(3‐hydroxybutyrate) in engineered strains of Pseudomonas putida via increased malonyl‐ CoA availability. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.70044
Vancouver
Favoino G, Krink N, Schwanemann T, Wierckx N, Nikel PI. Enhanced biosynthesis of poly(3‐hydroxybutyrate) in engineered strains of Pseudomonas putida via increased malonyl‐ CoA availability. Microbial Biotechnology. 2024. doi:10.1111/1751-7915.70044
BibTeX
@article{Favoino2024,
author = {Favoino, Giusi and Krink, Nicolas and Schwanemann, Tobias and Wierckx, Nick and Nikel, Pablo I},
title = {Enhanced biosynthesis of poly(3‐hydroxybutyrate) in engineered strains of Pseudomonas putida via increased malonyl‐ CoA availability},
journal = {Microbial Biotechnology},
year = {2024},
doi = {10.1111/1751-7915.70044}
}
EUVIMED